Marathon Bancorp, Inc. /MD/
For the period ended Jun 30, 2025. Filed Sep 26, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Sep 26, 2025
MBBC$14.47-2.1%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| | | | | | | |
|---|---|---|---|---|---|---|
| · · June 30, | ||||||
| | 2025 | 2024 | ||||
| Assets | | | | | | |
| Cash and due from banks | | $2,242,736 | | $2,977,438 | ||
| Federal funds sold | | 12,143,000 | | 7,495,000 | ||
| Cash and cash equivalents | | 14,385,736 | | 10,472,438 | ||
| Interest bearing deposits held in other financial institutions | | 237,247 | | 199,888 | ||
| Debt securities available for sale | | 5,201,279 | | 6,606,761 | ||
| Debt securities held to maturity, at amortized cost (fair value $373,568 and $394,081) | | 483,787 | | 510,276 | ||
| Loans, net of allowance of $1,708,269 and $1,797,116, respectively | | 200,795,706 | | 183,447,633 | ||
| Interest receivable | | 667,686 | | 597,768 | ||
| Foreclosed assets (OREO), net | | 996,373 | | 1,375,140 | ||
| Investment in restricted stock, at cost | | 1,329,413 | | 1,329,413 | ||
| Cash surrender value life insurance | | 9,242,673 | | 8,972,785 | ||
| Premises and equipment, net | | 3,883,537 | | 4,085,752 | ||
| Other assets | | 1,611,363 | | 1,698,142 | ||
| Total assets | | $238,834,800 | | $219,295,996 | ||
| Liabilities and Stockholders' Equity | | | | | | |
| Liabilities | | | | | | |
| Deposits | | | | | | |
| Non-interest bearing | | $22,466,092 | | $22,562,358 | ||
| Interest bearing | | 152,774,734 | | 150,418,396 | ||
| Federal Home Loan Bank (FHLB) advances | | 15,000,000 | | 13,000,000 | ||
| Other liabilities | | 2,884,753 | | 2,020,458 | ||
| Total liabilities | | 193,125,579 | | 188,001,212 | ||
| Commitments and Contingent Liabilities (See note 18) | | | | | | |
| Stockholders' Equity | | | | | | |
| Preferred stock, $.01 par value, 5,000,000 shares authorized, none issued | | | — | | | — |
| Common stock, $.01 par value, 20,000,000 shares authorized, 2,938,698 and 2,938,362 | | | | | | |
| shares issued and outstanding at June 30, 2025 and 2024 | | | 28,962 | | | 20,970 |
| Additional paid-in capital | | | 22,647,140 | | | 7,254,534 |
| Retained earnings | | 25,566,126 | | 25,523,681 | ||
| Unearned ESOP shares, at cost | | | (2,047,077) | | | (751,613) |
| Accumulated other comprehensive loss | | (485,930) | | (752,788) | ||
| Total stockholders' equity | | 45,709,221 | | 31,294,784 | ||
| Total liabilities and stockholders' equity | | $238,834,800 | | $219,295,996 | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.